Interestingly, VENTX and NANOG share activity in hematopoiesis by repressing the genes responsible for terminal differentiation (e.g., TAL1, KLF1) [160,161], as well as promoting leukemia [161,162,163]. This evidence concerns the gene NANOG and leukemia.